EQ
Price
$0.48
Change
+$0.01 (+2.13%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
16.38M
34 days until earnings call
SEOVF
Price
$0.13
Change
+$0.01 (+8.33%)
Updated
Apr 3 closing price
Capitalization
43.66M
Ad is loading...

EQ vs SEOVF

Header iconEQ vs SEOVF Comparison
Open Charts EQ vs SEOVFBanner chart's image
Equillium
Price$0.48
Change+$0.01 (+2.13%)
Volume$6K
Capitalization16.38M
SERNOVA BIOTHERAPEUTICS
Price$0.13
Change+$0.01 (+8.33%)
Volume$104.48K
Capitalization43.66M
EQ vs SEOVF Comparison Chart
Loading...
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EQ vs. SEOVF commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQ is a Hold and SEOVF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (EQ: $0.47 vs. SEOVF: $0.13)
Brand notoriety: EQ and SEOVF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EQ: 5% vs. SEOVF: 260%
Market capitalization -- EQ: $16.38M vs. SEOVF: $43.66M
EQ [@Biotechnology] is valued at $16.38M. SEOVF’s [@Biotechnology] market capitalization is $43.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EQ’s FA Score shows that 1 FA rating(s) are green whileSEOVF’s FA Score has 0 green FA rating(s).

  • EQ’s FA Score: 1 green, 4 red.
  • SEOVF’s FA Score: 0 green, 5 red.
According to our system of comparison, EQ is a better buy in the long-term than SEOVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EQ’s TA Score shows that 4 TA indicator(s) are bullish.

  • EQ’s TA Score: 4 bullish, 5 bearish.

Price Growth

EQ (@Biotechnology) experienced а -3.89% price change this week, while SEOVF (@Biotechnology) price change was +14.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

EQ is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SEOVF($43.7M) has a higher market cap than EQ($16.4M). SEOVF YTD gains are higher at: -14.000 vs. EQ (-37.316). EQ has higher annual earnings (EBITDA): -4.46M vs. SEOVF (-26.84M). EQ has more cash in the bank: 25.9M vs. SEOVF (1.21M). EQ has less debt than SEOVF: EQ (497K) vs SEOVF (546K). EQ has higher revenues than SEOVF: EQ (45.9M) vs SEOVF (0).
EQSEOVFEQ / SEOVF
Capitalization16.4M43.7M38%
EBITDA-4.46M-26.84M17%
Gain YTD-37.316-14.000267%
P/E RatioN/AN/A-
Revenue45.9M0-
Total Cash25.9M1.21M2,144%
Total Debt497K546K91%
FUNDAMENTALS RATINGS
EQ vs SEOVF: Fundamental Ratings
EQ
SEOVF
OUTLOOK RATING
1..100
5177
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
82
Overvalued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
9489
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EQ's Valuation (20) in the Biotechnology industry is somewhat better than the same rating for SEOVF (82) in the null industry. This means that EQ’s stock grew somewhat faster than SEOVF’s over the last 12 months.

SEOVF's Profit vs Risk Rating (96) in the null industry is in the same range as EQ (100) in the Biotechnology industry. This means that SEOVF’s stock grew similarly to EQ’s over the last 12 months.

EQ's SMR Rating (94) in the Biotechnology industry is in the same range as SEOVF (100) in the null industry. This means that EQ’s stock grew similarly to SEOVF’s over the last 12 months.

SEOVF's Price Growth Rating (89) in the null industry is in the same range as EQ (94) in the Biotechnology industry. This means that SEOVF’s stock grew similarly to EQ’s over the last 12 months.

SEOVF's P/E Growth Rating (100) in the null industry is in the same range as EQ (100) in the Biotechnology industry. This means that SEOVF’s stock grew similarly to EQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EQ
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRIB0.57-0.02
-2.57%
Trinity Biotech plc
IRT20.55-0.83
-3.88%
Independence Realty Trust
SSTI16.24-0.69
-4.08%
SoundThinking
CDW151.57-12.90
-7.84%
CDW Corp
MBUU28.71-2.90
-9.17%
Malibu Boats

SEOVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SEOVF has been loosely correlated with RLYB. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SEOVF jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEOVF
1D Price
Change %
SEOVF100%
+7.50%
RLYB - SEOVF
35%
Loosely correlated
-3.97%
PXXLF - SEOVF
29%
Poorly correlated
N/A
EQ - SEOVF
23%
Poorly correlated
-4.48%
BMEA - SEOVF
22%
Poorly correlated
-9.72%
TLPPF - SEOVF
13%
Poorly correlated
-0.88%
More